Viral vector-mediated transgenic cell therapy in regenerative medicine: safety of the process

Bibliography

• Heyde M, Partridge KA, Oreffo RO, et al. Gene therapy used for tissue engineering applications. J Pharm Pharmacol 2007;59(3):329-50
   PubMed Web of Science ®Google Scholar
• Seo SJ, Kim TH, Choi SJ, et al. Gene delivery techniques for adult stem cell-based regenerative therapy. Nanomedicine (Lond) 2013;8(11):1875-91
   PubMed Web of Science ®Google Scholar
• Zhang X, Godbey WT. Viral vectors for gene delivery in tissue engineering. Adv Drug Deliv Rev 2006;58(4):515-34
   PubMed Web of Science ®Google Scholar
• Giatsidis G, Dalla Venezia E, Bassetto F. The role of gene therapy in regenerative surgery: updated insights. Plast Reconstr Surg 2013;131(6):1425-35
   PubMed Web of Science ®Google Scholar
• Stroncek JD, Xue Y, Haque N, et al. In vitro functional testing of endothelial progenitor cells that overexpress thrombomodulin. Tissue Eng Part A 2011;17(15-16):2091-100
   PubMed Web of Science ®Google Scholar
• Santos JL, Pandita D, Rodrigues J, et al. Non-viral gene delivery to mesenchymal stem cells: methods, strategies and application in bone tissue engineering and regeneration. Curr Gene Ther 2011;11(1):46-57
   PubMed Web of Science ®Google Scholar
• Hao J, Varshney RR, Wang DA. Engineering osteogenesis and chondrogenesis with gene-enhanced therapeutic cells. Curr Opin Mol Ther 2009;11(4):404-10
   PubMed Web of Science ®Google Scholar
• Gauglitz GG, Jeschke MG. Combined gene and stem cell therapy for cutaneous wound healing. Mol Pharm 2011;8(5):1471-9
   PubMedGoogle Scholar
• Zhang F, Yao Y, Hao J, et al. A dual-functioning adenoviral vector encoding both transforming growth factor-beta3 and shRNA silencing type I collagen: construction and controlled release for chondrogenesis. J Control Release 2010;142(1):70-7
   PubMed Web of Science ®Google Scholar
• Yao Y, Zhang F, Pang PX, et al. In vitro study of chondrocyte redifferentiation with lentiviral vector-mediated transgenic TGF-beta3 and shRNA suppressing type I collagen in three-dimensional culture. J Tissue Eng Regen Med 2011;5(8):e219-27
   PubMed Web of Science ®Google Scholar
• Qian K, Huang CL, Chen H, et al. A simple and efficient system for regulating gene expression in human pluripotent stem cells and derivatives. Stem Cells 2014;32(5):1230-8
   PubMed Web of Science ®Google Scholar
• Vannucci L, Lai M, Chiuppesi F, et al. Viral vectors: a look back and ahead on gene transfer technology. New Microbiol 2013;36(1):1-22
   PubMed Web of Science ®Google Scholar
• Ibraheem D, Elaissari A, Fessi H. Gene therapy and DNA delivery systems. Int J Pharm 2014;459(1-2):70-83
   PubMed Web of Science ®Google Scholar
• Savulescu J. Harm, ethics committees and the gene therapy death. J Med Ethics 2001;27(3):148-50
   PubMed Web of Science ®Google Scholar
• Hareendran S, Balakrishnan B, Sen D, et al. Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them. Rev Med Virol 2013;23(6):399-413
   PubMed Web of Science ®Google Scholar
• Yla-Herttuala S. Endgame: glybera finally recommended for approval as the first gene therapy drug in the european union. Mol ther 2012;10(10):1831-2
   Google Scholar
• Manno CS, Pierce GF, Arruda VR, et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 2006;12(3):342-7
   PubMed Web of Science ®Google Scholar
• Mingozzi F, Maus MV, Hui DJ, et al. CD8(+) T-cell responses to adeno-associated virus capsid in humans. Nat Med 2007;13(4):419-22
   PubMed Web of Science ®Google Scholar
• Rogers GL, Martino AT, Aslanidi GV, et al. Innate immune responses to AAV vectors. Front Microbiol 2011;2:194
   PubMed Web of Science ®Google Scholar
• Hao J, Yao Y, Varshney RR, et al. Gene transfer and living release of transforming growth factor-beta3 for cartilage tissue engineering applications. Tissue Eng Part C Methods 2008;14(4):273-80
   PubMed Web of Science ®Google Scholar
• Stercz B, Perlstadt H, Nagy K, et al. Immunochemistry of adenoviruses: limitations and new horizons of gene therapy. Acta Microbiol Immunol Hung 2013;60(4):447-59
   PubMed Web of Science ®Google Scholar
• Armbruster N, Weber C, Wictorowicz T, et al. Ex vivo gene delivery to synovium using foamy viral vectors. J Gene Med 2014;16(7-8):166-78
   PubMed Web of Science ®Google Scholar
• Xiao C, Zhou H, Liu G, et al. Bone marrow stromal cells with a combined expression of BMP-2 and VEGF-165 enhanced bone regeneration. Biomedical materials (Bristol, England) 2011;6(1):015013
   Google Scholar
• Available from: http://www.mesoblast.com/products/overview
   Google Scholar
• Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007;110(10):3499-506
   PubMed Web of Science ®Google Scholar
• Rasmusson I, Ringden O, Sundberg B, et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003;76(8):1208-13
   PubMed Web of Science ®Google Scholar
• Hodgkinson CP, Gomez JA, Mirotsou M, et al. Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther 2010;21(11):1513-26
   PubMed Web of Science ®Google Scholar
• Chen L, Tredget EE, Wu PYG, et al. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008;3(4):e1886
   PubMed Web of Science ®Google Scholar
• Treacy O, Ryan AE, Heinzl T, et al. Adenoviral transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation. PLoS One 2012;7(8):e42662
   PubMedGoogle Scholar
• Sheyn D, Mizrahi O, Benjamin S, et al. Genetically modified cells in regenerative medicine and tissue engineering. Adv Drug Deliv Rev 2010;62(7-8):683-98
   PubMed Web of Science ®Google Scholar
• Bleiziffer O, Eriksson E, Yao F, et al. Gene transfer strategies in tissue engineering. J Cell Mol Med 2007;11(2):206-23
   PubMed Web of Science ®Google Scholar
• Harrison RH, St-Pierre JP, Stevens MM. Tissue engineering and regenerative medicine: a year in review. Tissue Eng Part B Rev 2014;20(1):1-16
   PubMed Web of Science ®Google Scholar
• Meyerrose T, Olson S, Pontow S, et al. Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev 2010;62(12):1167-74
   PubMed Web of Science ®Google Scholar
• Gurusinghe S, Strappe P. Gene modification of mesenchymal stem cells and articular chondrocytes to enhance chondrogenesis. Biomed Res Int 2014;2014:369528
   PubMedGoogle Scholar
• Kimelman Bleich N, Kallai I, Lieberman JR, et al. Gene therapy approaches to regenerating bone. Adv Drug Deliv Rev 2012;64(12):1320-30
   PubMed Web of Science ®Google Scholar
• Madry H, Kaul G, Zurakowski D, et al. Cartilage constructs engineered from chondrocytes overexpressing IGF-I improve the repair of osteochondral defects in a rabbit model. Eur Cell Mater 2013;25:229-47
   PubMed Web of Science ®Google Scholar
• Ferreira JR, Hirsch ML, Zhang L, et al. Three-dimensional multipotent progenitor cell aggregates for expansion, osteogenic differentiation and ’in vivo’ tracing with AAV vector serotype 6. Gene ther 2013;20(2):158-68
   PubMed Web of Science ®Google Scholar
• Chaofeng W, Chao Z, Deli W, et al. Nucleus pulposus cells expressing hBMP7 can prevent the degeneration of allogenic IVD in a canine transplantation model. J Orthop Res 2013;31(9):1366-73
   PubMed Web of Science ®Google Scholar
• He X, Dziak R, Mao K, et al. Integration of a novel injectable nano calcium sulfate/alginate scaffold and BMP2 gene-modified mesenchymal stem cells for bone regeneration. Tissue Eng Part A 2013;19(3-4):508-18
   PubMed Web of Science ®Google Scholar
• Zhu C, Chang Q, Zou D, et al. LvBMP-2 gene-modified BMSCs combined with calcium phosphate cement scaffolds for the repair of calvarial defects in rats. J Mater Sci Mater Med 2011;22(8):1965-73
   PubMed Web of Science ®Google Scholar
• Uchida S, Itaka K, Nomoto T, et al. An injectable spheroid system with genetic modification for cell transplantation therapy. Biomaterials 2014;35(8):2499-506
   PubMed Web of Science ®Google Scholar
• Zhou L, Chen Z, Vanderslice P, et al. Endothelial-like progenitor cells engineered to produce prostacyclin rescue monocrotaline-induced pulmonary arterial hypertension and provide right ventricle benefits. Circulation 2013;128(9):982-94
   PubMed Web of Science ®Google Scholar
• Tan C, Lui PP, Lee YW, et al. Scx-transduced tendon-derived stem cells (tdscs) promoted better tendon repair compared to mock-transduced cells in a rat patellar tendon window injury model. PLoS One 2014;9(5):e97453
   PubMedGoogle Scholar
• Rustad KC, Gurtner GC. Mesenchymal stem cells home to sites of injury and inflammation. Adv Wound Care (New Rochelle) 2012;1(4):147-52
   Google Scholar
• Samper E, Diez-Juan A, Montero JA, et al. Cardiac cell therapy: boosting mesenchymal stem cells effects. Stem Cell Rev 2013;9(3):266-80
   PubMed Web of Science ®Google Scholar
• Zhu XY, Lerman A, Lerman LO. Concise review: mesenchymal stem cell treatment for ischemic kidney disease. Stem Cells 2013;31(9):1731-6
   PubMed Web of Science ®Google Scholar
• Zhang W, Yan Q, Zeng YS, et al. Implantation of adult bone marrow-derived mesenchymal stem cells transfected with the neurotrophin-3 gene and pretreated with retinoic acid in completely transected spinal cord. Brain Res 2010;1359:256-71
   PubMed Web of Science ®Google Scholar
• Sullivan C, Barry F, Ritter T, et al. Allogeneic murine mesenchymal stem cells: migration to inflamed joints in vivo and amelioration of collagen induced arthritis when transduced to express CTLA4Ig. Stem Cells Dev 2013;22(24):3203-13
   PubMed Web of Science ®Google Scholar
• De Rosa L, Carulli S, Cocchiarella F, et al. Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. Stem Cell Reports 2014;2(1):1-8
   PubMed Web of Science ®Google Scholar
• Lu P, Zhang GR, Cai YZ, et al. Lentiviral-encoded shRNA silencing of proteoglycan decorin enhances tendon repair and regeneration within a rat model. Cell Transplant 2013;22(9):1507-17
   PubMed Web of Science ®Google Scholar
• Venkatesan JK, Ekici M, Madry H, et al. SOX9 gene transfer via safe, stable, replication-defective recombinant adeno-associated virus vectors as a novel, powerful tool to enhance the chondrogenic potential of human mesenchymal stem cells. Stem Cell Res ther 2012;3(3):22
   PubMed Web of Science ®Google Scholar
• Helmrich U, Di Maggio N, Guven S, et al. Osteogenic graft vascularization and bone resorption by VEGF-expressing human mesenchymal progenitors. Biomaterials 2013;34(21):5025-35
   PubMed Web of Science ®Google Scholar
• Helmrich U, Marsano A, Melly L, et al. Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purification. Tissue Eng Part C Methods 2012;18(4):283-92
   PubMed Web of Science ®Google Scholar
• Bakhtina A, Tohfafarosh M, Lichtler A, et al. Characterization and differentiation potential of rabbit mesenchymal stem cells for translational regenerative medicine. In Vitro Cell Dev Biol Anim 2014;50(3):251-60
   PubMed Web of Science ®Google Scholar
• Li JF, Yin HL, Shuboy A, et al. Differentiation of hUC-MSC into dopaminergic-like cells after transduction with hepatocyte growth factor. Mol Cell Biochem 2013;381(1-2):183-90
   PubMed Web of Science ®Google Scholar
• Chen Q, Yang Z, Sun S, et al. Adipose-derived stem cells modified genetically in vivo promote reconstruction of bone defects. Cytotherapy 2010;12(6):831-40
   PubMed Web of Science ®Google Scholar
• Zou D, Zhang Z, He J, et al. Blood vessel formation in the tissue-engineered bone with the constitutively active form of HIF-1alpha mediated BMSCs. Biomaterials 2012;33(7):2097-108
   PubMed Web of Science ®Google Scholar
• Shui W, Zhang W, Yin L, et al. Characterization of scaffold carriers for BMP9-transduced osteoblastic progenitor cells in bone regeneration. J Biomed Mater Res A 2013;102(10):3429-38
   PubMed Web of Science ®Google Scholar
• Zhang F, Yao Y, Su K, et al. Co-transduction of lentiviral and adenoviral vectors for co-delivery of growth factor and shRNA genes in mesenchymal stem cells-based chondrogenic system. J Tissue Eng Regen Med 2012. [ Epub ahead of print]
   Google Scholar
• Yang X, Shang H, Katz A, et al. A modified aggregate culture for chondrogenesis of human adipose-derived stem cells genetically modified with growth and differentiation factor 5. Biores Open Access 2013;2(4):258-65
   Google Scholar
• Qi BW, Yu AX, Zhu SB, et al. Chitosan/poly(vinyl alcohol) hydrogel combined with Ad-hTGF-beta1 transfected mesenchymal stem cells to repair rabbit articular cartilage defects. Exp Biol Med (Maywood) 2013;238(1):23-30
   PubMed Web of Science ®Google Scholar
• Wang ZH, Li XL, He XJ, et al. Delivery of the Sox9 gene promotes chondrogenic differentiation of human umbilical cord blood-derived mesenchymal stem cells in an in vitro model. Braz J Med Biol Res 2014;47(4):279-86
   PubMed Web of Science ®Google Scholar
• Park SY, Kim KH, Gwak EH, et al. Ex vivo bone morphogenetic protein 2 gene delivery using periodontal ligament stem cells for enhanced re-osseointegration in the regenerative treatment of peri-implantitis. J Biomed Mater Res A 2015;103(1):38-47
   PubMed Web of Science ®Google Scholar
• Zou D, Zhang Z, He J, et al. Repairing critical-sized calvarial defects with BMSCs modified by a constitutively active form of hypoxia-inducible factor-1alpha and a phosphate cement scaffold. Biomaterials 2011;32(36):9707-18
   PubMed Web of Science ®Google Scholar
• Zou D, He J, Zhang K, et al. The bone-forming effects of HIF-1alpha-transduced BMSCs promote osseointegration with dental implant in canine mandible. PLoS One 2012;7(3):e32355
   PubMedGoogle Scholar
• Lin RZ, Dreyzin A, Aamodt K, et al. Induction of erythropoiesis using human vascular networks genetically engineered for controlled erythropoietin release. Blood 2011;118(20):5420-8
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhen R, Jiang M, et al. Development of all-in-one multicistronic Tet-On lentiviral vectors for inducible co-expression of two transgenes. Biotechnol Appl Biochem 2014. [Epub ahead of print]
   Web of Science ®Google Scholar
• Jung Y, Bauer G, Nolta JA. Concise review: induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells 2012;30(1):42-7
   PubMed Web of Science ®Google Scholar
• Hong SG, Dunbar CE, Winkler T. Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells. Mol Ther 2013;21(2):272-81
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Garrigue A, Wang GP, et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 2008;118(9):3132-42
   PubMed Web of Science ®Google Scholar
• Filareto A, Parker S, Darabi R, et al. An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells. Nat Commun 2013;4:1549
   PubMed Web of Science ®Google Scholar
• Jarmin S, Kymalainen H, Popplewell L, et al. New developments in the use of gene therapy to treat Duchenne muscular dystrophy. Expert Opin Biol Ther 2014;14(2):209-30
   PubMed Web of Science ®Google Scholar